PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product
• Global nuclear medicine equipment market
• Global SPECT market
• Global PET market
• Global radiopharmaceuticals market
PART 07: Market segmentation by application
• Oncology
• Cardiology
• Neurology
PART 08: Market segmentation by end-user
• Diagnostic centers
• Hospitals
• Research centers
PART 09: Geographical segmentation
• Global nuclear medicine market in Americas
• Reimbursement of radiopharmaceuticals in US
• Global nuclear medicine market in EMEA
• Global nuclear medicine market in APAC
PART 10: Market drivers
• High demand for SPECT and PET imaging
• Rising incidence of cancer and CVDs
• Growing demand for radiopharmaceuticals
PART 11: Impact of drivers
PART 12: Market challenges
• High cost of nuclear medicine and time constraints owing to its short half-life
• Shortage of nuclear medicine
• Regulatory hurdles
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Partnerships for development of nuclear medicine
• Production based on cyclotron
• Growing funding for R&D
PART 15: Vendor landscape
• Competitive scenario
PART 16: Key vendors
• Cardinal Health
• Digirad
• GE Healthcare
• Lantheus Medical Imaging
• Philips Healthcare
• Other prominent vendors
PART 17: Appendix
• List of abbreviations
PART 18: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Radioisotopes used in medical imaging
Exhibit 03: Global nuclear medicine market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global nuclear medicine market segmentation by product
Exhibit 06: Global nuclear medicine market segmentation by product 2015
Exhibit 07: Global nuclear medicine market segmentation by product 2020
Exhibit 08: Global nuclear medicine equipment market 2015-2020 ($ billions)
Exhibit 09: Global SPECT market 2015-2020 ($ billions)
Exhibit 10: Global PET market 2015-2020 ($ millions)
Exhibit 11: Global radiopharmaceuticals market 2015-2020 ($ billions)
Exhibit 12: Global nuclear medicine market segmentation by application 2015
Exhibit 13: Global nuclear medicine market segmentation by end-user 2015
Exhibit 14: Global nuclear medicine market segmentation by geography 2015
Exhibit 15: Global nuclear medicine market segmentation by geography 2020
Exhibit 16: Global nuclear medicine market segmentation by geography 2015-2020
Exhibit 17: Global nuclear medicine market segmentation by geography 2015-2020 ($ billions)
Exhibit 18: Conditions diagnosed using nuclear medicine (in the US)
Exhibit 19: Nuclear medicine market in Americas 2015-2020 ($ billions)
Exhibit 20: Components for Medicare reimbursement
Exhibit 21: Difference in Medicare based on hospital facility and physician’s offices
Exhibit 22: Reimbursement provided by Medicare for various nuclear medicines 2015
Exhibit 23: Nuclear medicine market in EMEA 2015-2020 ($ billions)
Exhibit 24: Nuclear medicine market in APAC 2015-2020 ($ millions)
Exhibit 25: Impact of drivers
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Cardinal Health: Product portfolio
Exhibit 28: Cardinal Health: Key takeaways
Exhibit 29: Digirad: Business segmentation by revenue 2015
Exhibit 30: Digirad: Business segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 31: Digirad: Key takeaways
Exhibit 32: GE Healthcare: Product portfolio
Exhibit 33: GE Healthcare: Key takeaways
Exhibit 34: Lantheus Medical Imaging: Product portfolio
Exhibit 35: Regulatory product approvals
Exhibit 36: Lantheus Medical Imaging: Product segmentation by revenue 2015
Exhibit 37: Lantheus Medical Imaging: Product segmentation by revenue 2014 and 2015 ($ millions)
Exhibit 38: Lantheus Medical Imaging: Key takeaways
Exhibit 39: Philips Healthcare: Product portfolio
Exhibit 40: Philips Healthcare: Key takeaways
Exhibit 41: Other prominent vendors
【掲載企業】
Cardinal Health, Digirad, GE Healthcare, Lantheus Medical Imaging, Philips Healthcare, ABT Molecular Imaging, Advanced Accelerator Applications, AGFA Healthcare, Algeta, Astellas Pharma, Bayer, Bracco Imaging, Brain Biosciences, Capintec, CMR Naviscan, Cubresa, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, IBA Molecular Imaging, ISOLOGIC Innovative Radiopharmaceuticals, Jubilant DraxImage, Mallinckrodt, Mediso Medical Imaging System, Mirada Medical, Navidea Biopharmaceuticals, Nordion, Piramal Imaging, Positron Pharmaceutical Company, RadioMedix, SHINE Medical Technologies, Sophie Biosciences, Toshiba Medical Systems, Triad Isotopes, Voxel.
【資料のキーワード】
核医学装置、SPECT、PET、放射性医薬品、医療
【調査方法】
一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)
【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。